Literature DB >> 15036704

Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia.

Andrea L Tranquilli1, Valeria Bezzeccheri, Stefano R Giannubilo, Caterina Scagnoli, Laura Mazzanti, Giuseppe G Garzetti.   

Abstract

OBJECTIVE: To assess whether amniotic fluid concentrations of nitric oxide (NO) and vascular endothelial growth factor (VEGF) in early pregnancy correlate to subsequent preeclampsia. STUDY
DESIGN: We performed a retrospective study to assess VEGF and NO on the second trimester amniotic fluid of 15 healthy women, and 15 women who subsequently developed preeclampsia.
RESULTS: In women with subsequent preeclampsia, both VEGF (213.19+/-78.42 pg/ml) and NO concentrations (4.31+/-1.02 micromol/mg creatinine) were significantly lower than healthy controls (VEGF 255.05+/-88.66 pg/ml; NO 5.02+/-1.57 microg/mg creatinine; P<0.05).
CONCLUSIONS: Our findings suggest that reduced VEGF may be responsible, at least in part, for the impaired vascular development which occurs in preeclampsia. Low concentrations of VEGF and NO in the second trimester may represent an impaired stimulus to vascular formation and endothelial regulation that induce placental disease and preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036704     DOI: 10.1016/S0301-2115(03)00369-5

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  8 in total

1.  Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease.

Authors:  Asa Johansson; Joanne E Curran; Matthew P Johnson; Katy A Freed; Mona H Fenstad; Line Bjørge; Irina P Eide; Melanie A Carless; David L Rainwater; Harald H H Goring; Rigmor Austgulen; Eric K Moses; John Blangero
Journal:  Eur J Hum Genet       Date:  2011-02-23       Impact factor: 4.246

2.  Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.

Authors:  Jeffrey S Gilbert; Joseph Verzwyvelt; Drew Colson; Marietta Arany; S Ananth Karumanchi; Joey P Granger
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

Review 3.  Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections.

Authors:  Jeffrey S Gilbert; Mark J Nijland; Penny Knoblich
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-11

4.  Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women.

Authors:  Sarah N Cross; Elena Ratner; Thomas J Rutherford; Peter E Schwartz; Errol R Norwitz
Journal:  Rev Obstet Gynecol       Date:  2012

Review 5.  An unexpected tail of VEGF and PlGF in pre-eclampsia.

Authors:  David O Bates
Journal:  Biochem Soc Trans       Date:  2011-12       Impact factor: 5.407

Review 6.  Role of oxidative stress in female reproduction.

Authors:  Ashok Agarwal; Sajal Gupta; Rakesh K Sharma
Journal:  Reprod Biol Endocrinol       Date:  2005-07-14       Impact factor: 5.211

Review 7.  Review on the role of glutathione on oxidative stress and infertility.

Authors:  Oyewopo Adeoye; Johnson Olawumi; Adeleke Opeyemi; Oyewopo Christiania
Journal:  JBRA Assist Reprod       Date:  2018-03-01

8.  Serum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patients.

Authors:  Marjan Noorbakhsh; Maryam Kianpour; Mehdi Nematbakhsh
Journal:  ISRN Obstet Gynecol       Date:  2013-09-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.